Search

  • HOME
  • Search
Original Articles
Lung Cancer
Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis
Seung Sook Paik, In Kyoung Hwang, Myung Jae Park, Seung Hyeun Lee
Tuberc Respir Dis. 2018;81(2):148-155.   Published online March 7, 2018
Full textFull text    PubreaderPubReader    PDFPDF    
Efficacy of Pemetrexed in Relapsed Non-Small Cell Lung Cancer and Thymidylate Synthase Expression.
Choel Kyu Park, Kyu Sik Kim, In Jae Oh, Manaljav Tseden-Ish, Yoo Duk Choi, Yong Soo Kwon, Yoo Il Kim, Sung Chul Lim, Young Chul Kim
Tuberc Respir Dis. 2009;67(3):191-198.   Published online September 1, 2009
PDFPDF    
Efficacy and Safety of Pemetrexed in Advanced Non-Small Cell Lung Carcinoma.
Gyu Jin Lee, Mann Hong Jung, Tae Won Jang, Chul Ho Ok, Hyun Joo Jung
Tuberc Respir Dis. 2009;67(2):121-126.   Published online August 1, 2009
PDFPDF    
Case Reports
Dramatic Tumor Response to 2nd-line Pemetrexed/Cisplatin Combination Chemotherapy in Patient with Malignant Pleural Mesothelioma..
Seung Min Lee, Soon Young Ko, Tae Ho Seo, Jung Hyun Lee, Seung Oh Choi, Jeong Geun Lee, Wan Seop Kim, Tae Hoon Lee, Gwang Ha Yoo, Kye Young Lee
Tuberc Respir Dis. 2007;62(5):432-436.   Published online May 1, 2007
PDFPDF    

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184



ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next